O
GWPH

OrbiMed’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

OrbiMed’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-21,000
Closed -$3.63M – 160
2018
Q3 		$3.63M Hold
21,000
– – 0.04% 132
2018
Q2 		$2.93M Sell
21,000
-53,000
-72% -$7.53M 0.03% 137
2018
Q1 		$8.34M Buy
74,000
+29,600
+67% +$3.72M 0.1% 110
2017
Q4 		$5.86M Sell
44,400
-516,671
-92% -$60.7M 0.07% 114
2017
Q3 		$56.9M Hold
561,071
– – 0.54% 55
2017
Q2 		$56.2M Buy
561,071
+85,171
+18% +$9.17M 0.59% 53
2017
Q1 		$57.6M Buy
475,900
+79,300
+20% +$9.73M 0.65% 46
2016
Q4 		$44.3M Buy
396,600
+360,400
+996% +$43.4M 0.56% 51
2016
Q3 		$4.8M Buy
+36,200
New +$3.46M 0.05% 118
2016
Q2 		– Sell
-190,600
Closed -$13.8M – 148
2016
Q1 		$13.8M Sell
190,600
-113,500
-37% -$6.23M 0.14% 74
2015
Q4 		$21.1M Sell
304,100
-73,000
-19% -$5.95M 0.19% 69
2015
Q3 		$34.5M Buy
377,100
+52,100
+16% +$5.79M 0.35% 57
2015
Q2 		$39.9M Buy
325,000
+123,000
+61% +$14M 0.33% 60
2015
Q1 		$18.4M Buy
+202,000
New +$16.4M 0.16% 82
2014
Q4 		– Sell
-221,000
Closed -$17.9M – 141
2014
Q3 		$17.9M Buy
+221,000
New +$19.6M 0.19% 80
2014
Q2 		– Sell
-95,500
Closed -$5.67M – 148
2014
Q1 		$5.67M Sell
95,500
-224,700
-70% -$13.4M 0.07% 113
2013
Q4 		$13.3M Buy
+320,200
New +$10.1M 0.2% 74

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

OrbiMed's GWPH Position: Q4 2018 in Review

OrbiMed sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2018, closing a stake of 21,000 shares — an estimated $3.63M sold.

OrbiMed first reported a position in GWPH in Q4 2013 and held it in 17 quarters. The position peaked at $57.6M in Q1 2017. 277 funds tracked by Wall St. Rank hold GWPH as of Q4 2018.

  • OrbiMed reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2018 after selling out during the quarter.
  • OrbiMed sold 21,000 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2018, an estimated $3.63M.
  • OrbiMed first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2013 and held it in 17 quarters.
  • OrbiMed's GW Pharmaceuticals Plc American Depositary Shares position peaked at $57.6M in Q1 2017.
  • 277 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2018.

Based on OrbiMed's 13F filing for Q4 2018, filed 14 Feb 2019.